NCT01026844View on ClinicalTrials.gov

Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)

PHASE1TerminatedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

erlotinib

Taken orally once a day

DRUG

hydroxychloroquine

Taken orally once a day

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER